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Although alpha-adrenergic stimulation can increase
coronary vascular resistance, it remains unknownwhether
the vasoconstriction can override intrinsic COronary reg-
ulatory influences to produce ischemia. Methoxamine, 2
to 4 mg, was infused into the circumflex coronary artery
of 23 chloralose-anesthetized open chest dogs, and re-
sulted in a 68% increase in coronary vascular resistance.
The functional consequence ofthls increased coronary
vascular resistance was assessed by gated radionuclide
ventriculography and ST-T wave changes on the
electrocardiogram.
In six dogs (Group I), aortic pressure changed triv-
ially «5 mm Hg) to allow distinction between direct
effects of the flow reduction and indirect effects of in-
creased aortic pressure. In this group, coronary blood
flow decreased 33% from a control value of 44 ± 10
ml/min (p < 0.001) and left ventricular ejection fraction
decreased from 0.54 ± 0.12 to 0.46 ± 0.10 (p < 0.025).
In eight dogs (Group II) in which aortic pressure in-
Primary alpha-adrenergic receptor-mediated coronary va-
soconstriction and secondary metabolic vasodilation are
competitive with one another (1). Alpha-adrenergic stim-
ulation has been shown to cause increased coronary vascular
resistance (2,3), narrowing of the large coronary arteries (4)
and decreased oxygen tension in the coronary venous blood
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creased by more than 5 mm Hg, left ventricular ejection
fraction decreased from 0.46 ± 0.07 to 0.39 ± 0.09
(p < 0.002). Pressure gradients were measured between
the aorta and a distal coronary artery branch to calculate
small and large vesselresistances separately in four other
dogs (Group III) ..The resistance of small coronary ar-
teries accounted for 92% of the total increase in coronary
vascular resistance produced by methoxamine. In five
other dogs (Group IV), intracoronary methoxamine, 2
mg, produced ST-T wave changes suggestiveof ischemia
as it increased coronary vascular resistance by 33%.
In conclusion, this study demonstrated that meth-
oxamine caused functionally significant vasoconstriction
of small coronary arteries as shown by the decreased left
ventricular ejection fraction and ST-T wave changes.
These findings suggest that alpha-adrenergic vasocon-
striction can override coronary regulatory influences to
cause ischemia.
(1 Am Coli CardioI1986;8:885-93)
(5). The decrease in coronary venous oxygen tension is
presumably caused by increased oxygen extraction. It is not
known whether this increased oxygen extraction reflects a
severe enough depression in coronary blood flow so that
alpha-adrenergic stimulation actually overcomes the intrin-
sic coronary regulation to reduce tissue oxygenation and
precipitate ischemia, Thus, the first goal of the present study
was to determine whether the increase in coronary vascular
resistance produced by intracoronary methoxamine causes
a Severeenough reduction in coronary blood flow to produce
myocardial ischemia, as indicated by impaired left ventric-
ular contractile function and ST-T wave changes on the
electrocardiogram. Left ventricular dysfunction could cer-
tainly be produced by factors other than acute myocardial
ischemia, so we designed this study to use left ventricular
ejection as an index of the functional significance of changes
in coronary vascular resistance, First, we selected meth-
oxamine as an alpha-adrenergic agonist because it causes
0735-1097/86/$3.50
886 MATURI ET AL.
ISCHEMIA DUE TO ALPHA-ADRENERGIC STIMULATION
lACC Vol. 8. No, 4
October 1986:885- 93
Aon,c Pressure 22 Gauge Cannula
Electromag netIC Flo.. Probe
'f Pneumat Ic Occluder
/If ':',.. Distal Coronary
, Pressure Catheter
LJ IDCPI• In _ 41, ~
" ~'-
""\.V Pacemaker
no direct negative inotropic effects (6,7). Second, we se-
lected one group of dogs (Group I) becau se of their trivial ,
(that is, less than 5 mm Hg) change in mean aortic pressure
with methoxamine, to avoid the effects on cardiac function
of changing afterload or baroreceptor reflexes.
The second major purpose of our investigation was to
determine whether methoxamine constricted primarily large
or small coronary arteries. Indirect evidence has suggested
that small vessels have minimal alpha-adrenergic receptor
function (8, 9), and that the predom inant effect of alpha-
adrenergic vasoconstriction is on large vessels (4). Recently
Kelley and Feigl (10) suggested a more significant role for
small vessels in vasoconstriction mediated by alph a-adre-
nergic receptors. However, these investigators studied only
small increases (not greater than 35%) in coronary vascular
resistance and did not determine whether these changes were
functi onally significant. Thu s, it could not be determined
whether functionally significant changes in coronary vas-
cular resistance sufficient to impair left ventricular contrac-
tile and electrophysiologic function requi re large vesse l in-
volvement , or can be med iated primarily by small vessel
constrictors .
Methods
Experimental preparation. Twenty-three foxhounds
weighing 25 to 35 kg were ane sthetized with morphine
sulfate , 3 rng/kg body weight intramu scularly, and alpha
chloralose , 3 g intravenous bolu s , then maintained on a 2
to 5 mg/h con stant infusion of chloralose in normal saline
solution. A left thoracotomy was performed and a pericar-
dial cradle was made. A I to 2 em segment of the proximal
left circumflex coronary artery was isolated to place an
Figure 1. Experimental preparation. Instrumentation
on the dog heart is shown on the left. The gamma
camera/computer system used to measure left ventric-
ular ejection fraction is shown on the right. LV = left
ventricular.
electromagnetic flow probe proximal to a pneumatic occlu-
der (Fig . 1). The pneumatic occluder was used to stop flow
momentarily to check the balance of the flow probe. A 22
gauge catheter was inserted retrograde into the proximal left
circumflex coronary artery for infusion of methoxamine .
Aortic pressure was monitored through a femoral artery
catheter registering mean pre ssure by a calibrated P23 ID
transducer. A constant heart rate was maintained by pacing
the apex of the left ventricle to obvi ate any possible changes
in atrioventricular conduction, except in the five dogs in
which the electrocardiogram was recorded. The dogs were
paced IO to 15% above their intrinsic heart rate to ensure
pacemaker capture. Arterial blood gases were monitored
periodically and maintained within normal limit s by ad-
justing ventilation.
Left ventricular function measurements. Radio-
nucl ide angiographic studies were performed in 14 dogs
given intracoronary methoxamine . These dogs were divided
into two groups based on changes in mean aortic pressure .
Because some dogs had trivial changes « 5 mm Hg) in
aortic pressure , this design perm itted evaluation of the ef-
fects of methoxamine on coronary blood flow and left ven-
tricular function without the confounding effects of in-
creased aortic pressure. In Group I (n = 6), aortic pressure
chan ged by less than 5 mm Hg (Fig . 2A) and in Group II
(n = 8), aortic pressure incre ased by 5 mm Hg or more
(Fig. 2B).
When conditions were stable, stannous pyrophosphate ,
3 mg, was injected intravenously, followed after 30 to 40
minutes by 20 mCi of technetium-99m. Electrocard io-
graphic-gated blood pool scintigraphy was performed by
imaging the dog with an El Scint model portable gamma
160 160 Figure 2. Mean aortic pressure during control statep< ,~ ~c. and during the maximal decrease in coronary bloodc. flow after treatment with methoxamine. To isolate:I: 120 :I: 120E 0 • E the effects of methoxamine on the coronary circu-i T q i~ .. lation independent of its effect on blood pressure,~ 8) ~ 8) Group I dogs (n = 6) were defined as having a less
".. e than 5 /TIm Hg increase in mean aortic pressure (left)<i: <i:
u u
whereas Group II dogs (n = 8) showed a greater'r 40 'r 400 0
« « than 5 mm Hg increase (right). Different symbols
are used for each individual dog and are consistent
0 0 in all figures. The heavy horizontal bars show mean
Control Methoxamine Control Metho xam ine
values. Lines connect points for the same dog.
Group I Group II
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scintillation camera. The dog was imaged in a modified left
anterior oblique projection that provided the best separation
between the right and left ventricles (11). The data were
collected in list mode on a Hewlett-Packard computer using
programs developed at the National Institutes of Health (12).
Briefly, the images were acquired to 6.2 million events over
6 to 10 minutes, and the computer-based electrocardio-
graphic-gating system constructed a cardiac image sequence
representing an average cardiac cycle (12). The data were
also used to construct a high temporal resolution (10 ms/frame)
left ventricular time-activity curve after manually outlining
regions of interest for the left ventricle and background.
The time-activity curve is proportional to changes in left
ventricular volume, and left ventricular ejection fraction was
calculated from the following equation:
End-diastolic counts - End-systolic counts
End-diastolic counts - Background counts
After the baseline gated blood pool scan, measurements
of coronary blood flow, aortic pressure, left ventricular pres-
sure and heart rate were made. Intracoronary saline solution
was injected as a control in six dogs and caused no change
in heart rate, coronary blood flow, aortic pressure or left
ventricular ejection fraction. Intracoronary methoxamine, 2
to 4 mg, was injected in 3 ml of saline solution over 1
minute, and repeat measurements, including the gated blood
pool scan, were made.
Total coronary vascular resistance was estimated by the
formula:
Mean aortic pressure
Mean coronary blood flow
where coronary back pressure is ignored, acknowledging
that the value of coronary back pressure is uncertain but
probably low in the open chest dog (13).
Measurement of large versus small vessel resistances.
In four separate dogs (Group III) an 18 gauge coronary
catheter that tapered to a 21 gauge tip was inserted in a
small distal branch of the circumflex coronary artery. A
differential pressure transducer monitored the difference be-
tween aortic and distal coronary artery pressure. This trans-
ducer was carefully calibrated in steps from 0 to 20 mm Hg
full scale; it recorded zero pressure difference when both
pressure inputs were attached to the same catheter, whether
it was reading zero or aortic pressure. The 18 gauge catheter
used in the coronary artery was inserted into a femoral artery
in separate pilot studies, and it did not alter the value of
mean pressure. If a pressure difference of less than 2 mrn
Hg was recorded, the animal was not used for the study,
using the criteria of Kelley and Feigl (10). Several animals
were prospectively judged unusable for this reason before
methoxamine was given. No animals were withdrawn ret-
rospectively.
Large (RL ) and small (Rs) vessel resistances were cal-
culated in successful experiments as follows:
AoP - DCP
Large vessel resistance = CBF = RL
DCP
Small vessel resistance = CBF = Rs,
where AoP = mean aortic pressure; DCP = mean distal
coronary pressure and CBF = coronary blood flow. In five
other dogs (Group IV), lead II of the electrocardiogram was
recorded before and during methoxamine administration.
Protocol. After control measurements was obtained, each
dog received intracoronary methoxamine, 2 to 4 mg, in 1
ml of normal saline solution infused over 1 minute, followed
by a 3 ml flush of normal saline solution over 1 minute.
After completing the methoxamine infusion, we recorded
the values of mean aortic pressure and heart rate at the time
of the maximal changes in mean coronary blood flow. In
Groups I (n = 6) and II (n = 8) we collected radionuclide
data for 6 to 10 minutes, beginning I minute after comple-
tion of the methoxamine infusion. In Group III (n = 4) we
measured distal coronary pressure and aortic pressure at the
time of maximal coronary blood flow changes due to meth-
oxamine. In Group IV (n = 5), we measured coronary
hemodynamics and recorded the electrocardiogram be-
fore and during the intracoronary methoxamine infusion
(n = 5).
Analysis of data. We tested the significance of differ-
ences from control to the maximal change after methox-
6
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Figure 3. Coronary hemodynamics in dogs with
a less than 5 mm Hg increase in aortic pressure
during methoxamine infusion (Group I). A, Coro-
nary blood flow decreased from the control period
to the timeof minimalcoronarybloodflow resulting
from methoxamine (10 to 15 seconds after com-
pletion of the infusion). B, Coronary vascular re-
sistance increased from the control period to the
time of minimal coronaryblood flow resulting from
methoxamine.
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Figure 4. In Group I dogs with a less than 5 mm Hg increase
in aortic pressure, left ventricularejection fraction decreased dur-
ing methoxamine treatment compared with the control state.
amine by Student's t test for paired data (14). Data are
presented as mean ± SD. A probability (p) value of less
than 0.05 was considered statistically significant but
0.05 < P < 0.10 was reported as marginally significant.
0.09 (p < 0.002) (Fig. 6). Reproducibility of the left ven-
tricular ejection fraction by gated blood pool scintigraphy
of two separate data acquisitions in the same dog a few
minutes apart was excellent. The absolute difference be-
tween paired serial studies separated by a saline injection
was 0.01 ± 0.01 ejection fraction units (p =: NS, n =: 7).
Large versus small vessel resistances. In Group III
(n = 4), aortic pressure did not change significantly (Fig .
7). Coronary blood flow decreased 28% from a control
of 43 ± 31 ml/min. Methoxamine increased large vessel
resistance from 0.18 ± 0.18 to 0.40 ± 0.33 mm Hg/ml
per min and small vessel resistance from 2.73 ± 1.51 to
5.72 ± 4.94 mm Hg/ml per min. When expressed as percent
of control, large vessel resistance increased 122 ± 106%
(p = 0.08) and small vessel resistance increased III ±
59% from control (p = 0.05). Although the percent in-
creases in large and small vessel resistances were similar,
the increase in small vessel resistance (Rs) accounted for
92% of the increase in total coronary vascular resistance:
Small vessel resistance
Large vessel resistance + Small vessel resistance '
Results
In Group I (n = 6), in which aortic pressure changed
less than 5 mm Hg and heart rate was held constant by
pacing so that it did not change from the control value of
97 ± 9 beats/min, coronary blood flow decreased from
44 ± 10 to 31 ± II ml/rnin (p < 0.001) (Fig. 3A). Coro-
nary blood flow remained at least 20% below baseline for
15 to 45 minutes. Coronary vascular resistance increased
55% from 2.28 ± 0.43 to 3.53 ± 1.27 mm Hg/ml per min
(p < 0.02) (Fig. 38). Left ventricular ejection fraction de-
creased from 0.54 ± 0.12 to 0.46 ± 0.10 (p < 0.025)
(Fig. 4).
In Group II (n = 8), in which aortic pressure increased
by 5 mm Hg or more (an average of 23%) and heart rate
was held constant so that it did not change from the control
value of 116 ± 22 beats/min, coronary blood flow decreased
from 50 ± 20 to 44 ± 23 mllmin (p < 0.05). Coronary
resistance increased 70% from 2.30 ± 1.27 to 3.91 ± 2.72
mm Hg/rnl per min (p < 0.02) (Fig. 5B). Left ventricular
ejection fraction decreased from 0.46 ± 0.07 to 0.39 ±
where large plus small vessel resistance (RL + Rs) = total
coronary vascular resistance. The increase in large vessel
resistance accounted for less than 8% of the total increase
in coronary vascular resistance due to methoxamine. There-
fore, the change in total resistance produced by methox-
amine was primarily due to its effect on small vessels. Thus,
small vessels exerted predominant control of coronary cir-
culation both during control conditions and during vaso-
constriction due to methoxamine (small vessel resistance =
94% of total resistance before and during methoxamine)
(Fig. 8).
In Group IV, methoxamine caused a 33% increase in
total coronary resistance and ST-T wave changes in all five
dogs (Table I) (Fig. 9). Intracoronary saline solution infused
at the same rate had no effect.
Discussion
Previous studies. Normally, endogenous regulatory
mechanisms control coronary blood flow to meet myocardial
metabolic demands (15) so that any coronary vasoconstrictor
p<.02
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Figure 5. Coronary hemodynamics in Group II dogs
with a greater than 5 mm Hg increase in aortic pres-
sure after methoxamine administration. A, Coronary
blood flow decreased from the control state to the
time of minimal coronary blood flow resulting from
treatment with methoxamine. B, Coronary vascular
resistance increasedfrom the control state to the time
of minimal coronary blood flow resulting from treat-
ment with methoxamine.
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Figure 6. In Group II dogs with a greater than 5 mrn Hg increase
in aortic pressure, left ventricul ar ejection fraction decreased dur-
ing methoxamine treatment compared with the control state.
agent would directly compete with this regulatory system
( 1,3) . The extent of this competition was studied by Feigl
(5), who found that alpha- adren ergic-med iated coronary
vasoconstriction is capable of lowering coronary venous
oxyge n tension . Mohrm an and Feigl ( I) corroborated this
by intracoronary infusion of norepinephrine in anesthetized
dogs with and without alpha-adrenergic receptor blockade;
they found that the resultin g alpha-adrenergic- mediated va-
soconstriction restricted coronary blood flow by about 30%
and caused a decrease in coro nary venous oxyge n tension .
A decrease in coron ary venous oxyge n tension is compatible
with, but not specific for, ischem ia . Although an agent
reduces coro nary blood flow, increased oxygen extraction
(measured by decre ased venous oxygen tension) may ade-
quately compensate for the decrease in flow (3) so that tissue
oxygenation is maintained and ischemia is prevented. Al-
ternatively, this decreased tension may reflect decreased
tissue oxygenation in which the alpha-adrenergic stimulation
actually overrides metabolically controlled coronary regu-
lation so that tissue oxyg enat ion decreases and ischemia
results (3) .
Infusion of norep inephrine in dogs with a fixed left main
stenosis was reported (16) to cause increased oxyge n de-
mand , decreased lactate extraction and eve ntual cardiac fail-
Figure 8. In Group III dogs, small vessel coronary vascular
resistance expressed as a fraction of the total coronary vascul ar
resistance did not change with methoxamine treatment (mean,
94%). This shows that small vessels exert predominant control
over the coronary circulati on both during the control state and
during treatment with methoxamine . Small vesse l resistance/(large
vessel resistance + small vessel resistance [Rs/(RL + Rs)]) =
small vessel resistance (Rs) as a fraction of total resistance (large
+ small vesse l resistance).
ure . This study did not deal with the question of whether
alpha-adrenergic stimulation, in itself, can produce myo-
cardial ischemia , in that any ischem ia produced was prob-
ably due to norepinephrine-induced increased oxygen de-
mand in the face of a critical left main coronary stenos is.
A similar study ( 17) showed that sympathetic nerve stim-
ulation in the presence of a coro nary stenosis severe enough
to abolish reactive hyperemia caused decreased sys tolic seg -
ment shortening and lactate production . Propranolol blocked
the increase in myocardial oxygen demand in this situation
and reverted gross lactate produ ction to a decreased lactate
consumption. Administration of norepinephrine in the pres-
ence of a moderately severe coronary stenosis did not produce
a decrease in coronary blood flow or evidence of myocardial
ischemia in two other studies (18, 19), presumably because
of direct and metabolically induced coronary vasodilation.
In summary, previous studies have not addressed the ques-
tion of whether alpha-adrenergic stimulation, as such, could
160 60~~0> ~c ! 50:rFigure 7. In Group III dogs (n = 4), in which E 120 ~large and small vessel resistances were studied, aor- E ~ 40~ 0 ~tic pressure (A) did not change with methoxamine ::l Ii:'" 80 'tl 30'"treatment. Coronary blood flow (B) decreased from III 0ci: 0
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Figure 9. In Group IV dogs (n =
5), intracoronary methoxamine, 2 mg,
increasedcoronary vascular resistance
which was associatedwith ST-T wave
changes on lead II of the electrocar-
diogram in each dog. Tracings are
shown for each dog before (left) and
during (right) methoxamine infusion.
Intracoronary saline solution infused
at the same rate had no effect.
constrict normal coronary arteries to produce acute myo-
cardial ischemia.
Evidence of ischemia during methoxamine infusion.
The purpose of the present study was to test the hypothesis
that alpha-adrenergic receptor stimulation by intracoronary
methoxamine can overcome endogenous regulatory influ-
ences so as to reduce blood flow sufficiently to produce
myocardial ischemia, as manifested by left ventricular dys-
function and ST-T wave changes on the electrocardiogram.
Demonstration of this functional significance of alpha-
adrenergic receptor-mediated vasoconstriction is important
in that it supports a potential role for alpha-adrenergic re-
ceptors in coronary vasoconstriction that is consistent with
some clinical studies (20,21). Our results support the va-
lidity of the hypothesis that coronary vasoconstriction
produced by methoxamine causes ST-T changes and de-
creases in both coronary blood flow and left ventricular
ejection fraction. These findings were present in dogs in
which aortic pressure and heart rate did not change and thus
suggest that coronary regulation may be overcome by alpha-
adrenergic stimulation to produce myocardial ischemia.
Effects of methoxamine on large versus small coro-
nary vessels. In the second part of this study we sought to
determine whether this functionally significant vasoconstric-
tion mediated by alpha-adrenergic receptor stimulation in-
volved predominantly the large or small coronary arteries.
These results demonstrate that although the percent increase
was similar for large, small and total coronary vascular
resistances, the resistance of small coronary arteries ac-
counted for over 94% of total resistance to indicate control
of the coronary circulation by small arteries before and
during methoxamine infusion. Because the absolute value
Table 1. Effects of Methoxamine on Coronary Hemodynamics in Dogs With
Electrocardiographic Records (Group IV, n = 5).
Mean Aortic Mean Coronary Coronary Resistance
Heart Rate Pressure Blood Flow (mm Hg/ml
Dog
(beats/min) (mm Hg) (mllmin) per min)
No. C M C M C M C M
I 119 125 135 150 24 21 5,62 7.14
2 140 135 83 92 59 52 1.35 1.64
3 180 180 122 125 51 41 2.39 3.04
4 102 100 75 108 26 22 2,88 4.68
5 110 115 67 72 34 31 I. 91 2.36
Mean 130 131 97 109* 39 33* 2.83 3.77*
±SD ± 31 ±30 ±31 ±30 ±16 ± 13 ± 1.66 ±2,19
*p < 0.05, C = control; M = methoxamine.
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of the resistance of large coronary arteries is such a small
percent of total resistance (6%), the increase in large vessel
resistance represented a trivial contribution (8%) to the ob-
served vasoconstriction. Thus, the primary site of the va-
soconstriction was at the level of small coronary arteries,
because 92% of the increase in total resistance was attributed
to the increase in small vessel resistance. Vatner et al. (4)
also found similar percent increases in large vessel and total
resistance with methoxamine, but small vessel resistance
could not be derived from their data. Although large vessel
involvement was documented elegantly by ultrasound crys-
tals, their data are consistent with our results. Although the
conclusion of Zuberbuhler and Bohr (8) differs from our
findings, one can question the applicability of their in vitro
study in which small coronary arteries may have been less
responsive to alpha-adrenergic stimulation because of dam-
age during dissection,
Our data are consistent with those of Kelley and Feigl
(10), who found similar increases in large vessel and total
resistance with alpha-adrenergic stimulation, Because small
vessel resistance was measured, one can calculate that the
actual contribution of large vessel resistance to the increase
in total resistance was less than 2%. Our results not only
corroborated their study but also provide an important ex-
tension. Kelley and Feigl (10) studied small changes in total
resistance that may not have been functionally significant.
A functionally significant increase in resistance might re-
quire involvement of large coronary arteries to overcome
endogenous regulation which occurs at the level of small
arteries. Our finding that vasoconstrictor influences on small
coronary arteries can cause myocardial ischemia is in agree-
ment with clinical data (22) suggesting that constriction of
small rather than large coronary arteries can cause myo-
cardial ischemic syndromes in many patients with variable
threshold angina.
Critique of methods. It is important to decide whether
the observed decrease in left ventricular ejection fraction,
from 0.54 to 0.46, is evidence of significant left ventricular
dysfunction. Because we used several control studies with
the same heart rate and aortic pressure, and imaged the same
anesthetized dog in the same position over a few minutes,
our serial studies are more reproducible than are clinical
studies. Ejection fraction measurements on the same dog
15 minutes apart by the same observer (n = 7) showed an
absolute difference of less than 0.01 ± 0.01 ejection frac-
tion units (p = NS). Therefore, a decrease of 0.08 ejection
fraction units from 0.54 units (15%) or 0.07 ejection fraction
units from 0.46 units (15%) is quite meaningful in this
highly controlled experimental environment.
A separate question is whether this decrease in left ven-
tricular ejection fraction can be interpreted as evidence of
ischemia. First, the methoxamine-induced coronary vaso-
constriction was associated with ST-T wave changes on the
electrocardiogram to suggest ischemia (Fig. 9). Left ven-
tricular dysfunction certainly cannot be equated with myo-
cardial ischemia, but this highly controlled experimental
setting was designed to minimize the possibility that other
potential causes could account for left ventricular dysfunc-
tion. For example, aortic pressure did not increase in Group
I dogs, so the decreased ejection fraction could not be at-
tributed to increased afterload (23), or to baroreceptor reflex
inhibition of contractile function (24). Further, there is evi-
dence that even large changes in carotid sinus pressure do
not alter left ventricular function unless aortic pressure changes
also (25).
Second. the possibility that intracoronary methoxamine
had a direct negative inotropic effect on the heart to explain
decreased left ventricular ejection fraction seems highly
unlikely. Considerable evidence indicates that methoxamine
has little or no direct inotropic effects over a wide dose
range, and that at very high concentrations in vitro it exerts
positive rather than negative inotropic effects (6,7,26-30).
Lee et al. (7) reported a positive inotropic effect of meth-
oxamine in vivo only at high doses of up to 6 mg/kg in
lambs. Although Siegl et al. (31) concluded that methox-
amine has a depressant effect, examination of all their pub-
lished data shows that measured tension was always greater
than the control value. Another study (32) reporting a neg-
ative inotropic effect of methoxamine did not control for
deterioration over time of a precarious dog heart-lung prep-
aration and used an enormous dose of methoxamine. The
most conclusive study (6) showed no effect of methoxamine
over a concentration range of 10- <) to 10 - (, moleslliter and
a positive inotropic effect over a concentration range of 10 (,
to 10 3 moles/liter in cat papillary muscles. Thus, our find-
ings strongly support the conclusion that the decrease in
coronary blood flow caused ischemia, which in turn led to
a reduction in left ventricular function. It is not surprising
that the 55% increase in coronary vascular resistance at
constant heart rate and aortic pressure would impair left
ventricular function. Several studies (33-35) have found
that a 10 to 20% decrease in coronary blood flow impaired
cardiac contraction.
In Group III dogs. the resistances of large and small
coronary arteries were determined from differential pressure
measurements to provide estimates of the responses of large
and small coronary arteries. The plastic catheter limited the
lowest size vessel that could be cannulated to about 0.9 mm
in diameter. During inflation of the pneumatic occluder on
the left circumflex coronary artery, there was a large drop
in pressure between the aorta and the distal coronary catheter
to show that the system could detect physiologically im-
portant spasm of large coronary arteries such as is observed
on angiography in humans (36), One could question the
physiologic implications of methoxamine's effects, but the
differences between alpha-adrenergic stimulation by cardiac
nerves versus methoxamine do not appear to be large on
careful analysis of the original data (24,37). Further, there
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are other sources of alpha-adrenergic stimulation, such as
circulating catecholamines, that can have important effects
on the coronary circulation (3).
There is some evidence that alpha-adrenergic receptors
in the canine coronary circulation are primarily of the alpha,
subtype, whereas methoxamine stimulates primarily alpha,
adrenergic receptors (38). Although the distinction between
these subtypes is not clear-cut (39), these results suggest
that our findings may be conservative because methoxamine
is only a weak alpha--adrenergic receptor agonist. If alpha.-
receptors had been stimulated more strongly, then coronary
vasoconstriction might have been more severe, suggesting
that our study of methoxamine underestimates the potential
role of alpha-adrenergic stimulation.
Clinical implications. The present study of activation
of coronary alpha receptors in dogs cannot prove that alpha
receptor stimulation causes ischemia in humans, but it may
be relevant to support a potential mechanism for coronary
artery constriction in disease states where the level of local
alpha-adrenergic stimulation may be greater than in the nor-
mal state. In this context the present study is useful in
demonstrating the potential for alpha-adrenergic stimulation
to cause constriction of small coronary arteries and isch-
emia. Further, the study of alpha-adrenergic-mediated va-
soconstriction suggests that it may be necessary to evaluate
coronary blood flow rather than large vessel dimensions to
assess the effects of alpha-adrenergic receptor stimulation
in humans (20,22).
We gratefully acknowledge the expert preparation of the manuscript by
Gail Gipson.
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